23andMe (ME) Scheduled to Post Quarterly Earnings on Tuesday

23andMe (NASDAQ:ME) is set to release its earnings data after the market closes on Tuesday, November 12th.

23andMe (NASDAQ:ME) last released its quarterly earnings data on Thursday, August 8th. The company reported ($2.80) EPS for the quarter. 23andMe had a negative net margin of 317.03% and a negative return on equity of 83.22%. The business had revenue of $40.41 million for the quarter, compared to analysts’ expectations of $50.30 million.

23andMe Stock Performance

Shares of NASDAQ:ME opened at $4.58 on Friday. The business has a 50-day simple moving average of $5.87 and a two-hundred day simple moving average of $7.82. 23andMe has a fifty-two week low of $4.57 and a fifty-two week high of $20.40. The firm has a market cap of $112.26 million, a price-to-earnings ratio of -0.18 and a beta of 1.26.

Analysts Set New Price Targets

Separately, TD Cowen lowered shares of 23andMe from a “strong-buy” rating to a “strong sell” rating in a research report on Wednesday, August 7th.

23andMe Company Profile

23andMe Holding Co operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.